5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.12▼ | 1.14▼ | 1.15▼ | 1.12▼ | 1.18▼ |
MA10 | 1.13▼ | 1.16▼ | 1.15▼ | 1.17▼ | 1.19▼ |
MA20 | 1.14▼ | 1.15▼ | 1.13▼ | 1.21▼ | 1.14▼ |
MA50 | 1.17▼ | 1.13▼ | 1.18▼ | 1.18▼ | 2.13▼ |
MA100 | 1.15▼ | 1.18▼ | 1.19▼ | 1.14▼ | 2.64▼ |
MA200 | 1.13▼ | 1.20▼ | 1.23▼ | 1.89▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.006▼ | 0.003▲ | -0.016▼ | 0.074▲ |
RSI | 18.159▼ | 38.352▼ | 41.231▼ | 43.609▼ | 39.215▼ |
STOCH | 7.500▼ | 8.652▼ | 58.203 | 17.787▼ | 55.076 |
WILL %R | -100.000▼ | -100.000▼ | -76.471▼ | -78.684▼ | -53.745 |
CCI | -148.052▼ | -171.951▼ | -44.899 | -55.792 | -2.460 |
Thursday, July 03, 2025 04:14 AM
Pyxis Oncology , Inc. (NASDAQ: PYXS) reported the retirement of Pamela Connealy from her roles as Chief Financial Officer and Chief Operating Officer, effective Tuesday.According to a statement based ...
|
Monday, June 30, 2025 01:41 PM
BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to ...
|
Monday, June 30, 2025 01:30 PM
BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 1.22 | 1.24 | 1.10 | 1.10 | 503,969 |
02/07/25 | 1.06 | 1.21 | 1.0404 | 1.20 | 591,627 |
01/07/25 | 1.10 | 1.1197 | 1.07 | 1.08 | 515,080 |
30/06/25 | 1.11 | 1.1599 | 1.10 | 1.10 | 371,848 |
27/06/25 | 1.21 | 1.22 | 1.10 | 1.10 | 6,619,489 |
26/06/25 | 1.30 | 1.32 | 1.17 | 1.18 | 511,468 |
25/06/25 | 1.30 | 1.3191 | 1.27 | 1.28 | 372,690 |
24/06/25 | 1.22 | 1.29 | 1.21 | 1.28 | 384,457 |
23/06/25 | 1.16 | 1.24 | 1.16 | 1.21 | 415,077 |
20/06/25 | 1.16 | 1.19 | 1.14 | 1.17 | 350,772 |
|
|
||||
|
|
||||
|
|